An M.D, D.D.s, M.B.A, C.E.O, Jack Kavanaugh, is a well-known doctor and business leader in the Medical Field. He has helped numerous technologies and health-related organizations to commercialize their business worldwide and has created and led companies like Calhoun Vision to create next-generation medical treatment.
Jack started his carrier as a successful dentist. He met with an accident and broke his neck and shattered his leg, which prevented him from practicing dentistry again. This misfortune incident in his life became a turning point, as he went on to earn his M.B.A from U.C.L.A and worked with his former managing/senior partner at McKenzie International. In 1984, they founded the International Strategy Consulting Group, a management and M.B.A consulting firm.
Kavanaugh continued his carrier in private equity; from here on, he again turned towards his medical field. He got his M.D degree from U.S.C and completed his surgical internship at U.C.L.A’s Jules Stein Institute. He remained a visiting professor at U.C.L.A and taught eye surgery to fellow residents till 2008. He founded Amerident, a healthcare service center during his first year of residency that was honored with more than 30 community services awards and state Congressional Medal of Honor for their work with the infants.
As Kavanaugh’s carrier continued in private organization, he held Calhoun Vision’s first Board meeting, which is a biotechnological organization that has developed a light adjustable lens used for cataract surgery. He served as a board member from 2000, later he was appointed as the chairman, from 2008 to 2012.
Dr. Jack has also worked with the board of PreCash, a telecommunication and financial service organization. In 2001, he turned away the insolvency proceeding and engineered a major turnaround. Two years later, Inc. Magazine declared PreCash as one of the fastest-growing companies of the United State of America.
In 2008, Dr. Jack Javanaugh founded ZetaRx Bioscience, Inc., an organization at the leading edge of immunotherapy for the treatment of cancer. He led this company as Chairman and CEO both till the end of June 2012 and remains a consultant to the Board. Zetex Company was sold out in the year 2013, to Juno Therapeutic which became its core components. In 2014, Juno Therapeutics was declared as the largest biotech IPO of the year by reaching a market cap of $ 5.5 billion.
This post first appeared on Dr. Jack Kavanaugh – A Versatile Personality, please read the originial post: here
